Hospital-acquired conditions declined by 13 percent between 2014 and 2017, preventing an estimated 20,500 deaths and $7.7 billion in health care costs, according to preliminary data from the Agency for Healthcare Research and Quality. HACs decreased by an estimated 910,000 over the period, including a 37 percent decline in C. difficile infections and 28 percent decline in adverse drug events, showing that patient safety initiatives such as the Hospital Improvement Innovation Networks are working to make health care safer, the agency said. AHA’s Health Research & Educational Trust leads the nation’s largest HIIN. 
 

Related News Articles

Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Blog
We must address the racial, ethnic and socioeconomic disparities that increase the risk of negative perinatal outcomes for women of color.
Blog
AHA Executive Vice President Maryjane Wurth previews AHA’s Team Training Conference, where different interdisciplinary groups from diverse health care settings…
Headline
The Food and Drug Administration today ordered manufacturers to immediately stop selling and distributing surgical mesh products for transvaginal repair of…
Headline
Readmissions penalties for hospitals with the greatest share of dually eligible beneficiaries could fall by an estimated $22.4 million in fiscal year 2019,…
Headline
The Centers for Medicare…